[ Price : $8.95]
CDER denies a 2006 citizen petition from physician John C. Kulli that requested it issue a regulation requiring attention deficit ...[ Price : $8.95]
FDA approves a de novo petition to allow the marketing of T2 Biosystems direct blood test for detecting five yeast pathogens that ...[ Price : $8.95]
FDA grants Regeneron Pharmaceuticals a breakthrough therapy designation for Eylea injection for treating diabetic retinopathy in p...[ Price : $8.95]
CDERs Office of Prescription Drug Promotion objects to a Cipher Pharmaceuticals e-Pharm/alert email for Lipofen (fenofibrate capsu...[ Price : $8.95]
A new House bill aims to close a loophole that is used by some brand drug makers to prevent potential generic drug firms from obta...[ Price : $8.95]
A special advisory bulletin from HHS Office of Inspector General raises concerns on the measures used by pharmaceutical manufactur...[ Price : $8.95]
FDA grants orphan drug status to Navidea Biopharmaceuticals for Lymphoseek Injection for sentinel lymph node detection in head and...[ Price : $8.95]
FDA assigns a user fee goal date for Salix Pharmaceuticals sNDA for Xifaxan for treating irritable bowel syndrome with diarrhea.